GlassScriptPhysician profile
Stanford K Shu
NPI 1548280340
$502.08
in general payments reported to CMS, 2019-2025
7 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.96 · 2021: $138 · 2022: $16.77 · 2024: $121 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuroone Medical Technologies Corporation | $130.84 | 2021 | |
| Ucb, INC. | $121.40 | 2024 | Briviact, Nayzilam |
| Springworks Therapeutics, INC. | $102.99 | 2025 | Gomekli |
| Mallinckrodt Enterprises LLC | $90.57 | 2019 | |
| Acadia Pharmaceuticals INC | $28.76 | 2025 | Daybue |
| Neurelis, INC. | $16.77 | 2022 | |
| Travere Therapeutics, INC. | $10.75 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanford Shu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.